title: Legislation governing the US incentive scheme for neglected diseases needs to be amended, urges MSF.
authors.affiliation: Médecins Sans Frontières-Access Campaign, 333 7th Avenue, 2nd Floor, New York, NY 10001, USA Jennifer.Reid@newyork.msf.org.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Reid
authors.affiliation: Médecins Sans Frontières-Access Campaign, 8 Rue Saint Sabin, 75011 Paris, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Potet
authors.affiliation: Médecins Sans Frontières-Access Campaign, Rue de Lausanne 78, CH-1211 Geneva 21, Switzerland.
authors.forename: Katy
authors.initials: K
authors.lastname: Athersuch
authors.affiliation: Médecins Sans Frontières-Access Campaign, Rue de Lausanne 78, CH-1211 Geneva 21, Switzerland.
authors.forename: Maisy
authors.initials: M
authors.lastname: Grovestock
authors.affiliation: Médecins Sans Frontières-Access Campaign, 333 7th Avenue, 2nd Floor, New York, NY 10001, USA.
authors.forename: Judit Rius
authors.initials: JR
authors.lastname: Sanjuan
mesh_terms: D035843:Biomedical Research / Q000331:legislation & jurisprudence*; D006801:Humans; D008493:Medical Missions; D009042:Motivation; D058069:Neglected Diseases / Q000628:therapy*; D014481:United States